Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0M26
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,325
Award facts
- Contract value 100% obligated
- $14,325.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,325.06 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on January 14, 2026, with an ultimate completion date of January 15, 2026, represents a non-set-aside award made through open and full competition. The pharmaceutical products will be delivered to the company's facility in Conshohocken, Pennsylvania. This award is a child task order under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the overarching vehicle for comprehensive global pharmaceutical support to military healthcare systems.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities worldwide. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a diverse range of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for DESCOVY, an antiretroviral medication, aligns with the company's established role in fulfilling essential pharmaceutical needs for federal healthcare systems through the DLA supply chain.
Quick answers
Who was awarded contract SPE2DR26F0M26?
SPE2DR26F0M26 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F0M26 worth?
The government has obligated $14,325 on SPE2DR26F0M26.
Is contract SPE2DR26F0M26 an order under another contract?
Yes. SPE2DR26F0M26 is a delivery order under SPE2DR25D2207, an indefinite delivery contract.
Was contract SPE2DR26F0M26 competed?
The extent of competition for SPE2DR26F0M26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award